We turn science into fundable ventures – and funded outcomes.
Our 98% success rate in over 130 deep tech projects and €80M+ secured & managed comes from radically rejecting the lean startup playbook and business-driven logic.
Instead, we apply a science-first approach to reverse-engineer venture building.
Through strategic narratives rooted in scientific inevitability, we attract the right capital to your innovation.
Our proprietary system is rooted in neuroscience, pattern recognition and data.
Want to actually succeed? Start here ↓
Fill out a short intake form. Within 3–5 days, you'll receive a free data-backed analysis:
– Where you stand
– What funding paths are viable
– What's missing - and why it matters
How it works
By thoroughly analyzing previous cases, enhanced by market trends and predictions, we apply our prioprietary 4x4 matrix to map:
→ technology scalability under physical & regulatory limitations (horizontal + vertical)
→ exit strategy + business model
→ early-stage asset monetization
→ funding opportunities (stacks of strategic + public + equity funds)
Why this approach
According to BCG, McKinsey and Hello Tomorrow, 92% of deep tech startups (and 70% of scienific innovation in general) fail.
Primary reasons are:
→ lack of structure and skills to translate breakthroughs into ventures
→ treating strategy as optional
→ forcing science into software playbooks
It's not because the science is bad. It's a systemic pattern. (Source: 1, 2, 3)
Why now
Time kills innovation. Most founders wait too long, or move too soon. Based on previous data (130+ supported projects and historical cases), and market analysis, it approximately takes:
→ 4-6 months to close an industry deal or monetize non-tangible assets
→ 6-9 months to close an investor deal
→ 9-12 months to get public funding and grant money.
Add 1-3 months of strategy development on top.
Serious about outcomes? So are we.
We engineer funding outcomes - for those already in the game.
If you’re
‣ in academia or pre-money but all-in,
‣ scaling horizontally or vertically, or
‣ investing and want fewer flops,
this is where the capital logic begins.
Interested in working with us?
We categorically reject the lean startup playbook. Science defies it by default.
Science-driven ventures aren’t just another kind of startup – they follow different laws. Literally. Physical constraints. Chemical boundaries. Regulatory frameworks.
None of that fits into MVPs, build-measure-learn loops, or imaginary TAM slides.
Those are just offensive to science.
At Arise, we start where the lean approach fails:
We work from the inside out – from molecular behavior to market architecture.
That’s the edge. That’s why it works.
We don't guess. We engineer fundability of what others called "non-fundable"
– and deliver results. Basta.
We're opinionated – very much so. See for yourself:
About
Maria Witte, CEO
Arise Innovations
- where science meets funding strategy
& Innovation becomes Reality
Our strength lies in developing tailor-made financing strategies for deep tech innovations that intelligently combine public funding, private investments and other resources.
With our expertise in acquiring financing and a strategic approach, we help companies discover hidden opportunities, successfully implement projects and secure long-term growth.
We accompany our clients through every phase – from ideation to scaling – and minimize risks while paving the way to sustainable success.
